Skip to main content

Table 2 Clinicopathological characteristics of 51 PTC patients

From: BRAFV600E mutation, BRAF-activated long non-coding RNA and miR-9 expression in papillary thyroid carcinoma, and their association with clinicopathological features

Characteristics

Patients (n)

Percent (%)

Sex

  

 Female

37

72.5

 Male

14

27.5

Age (years)

41.7 ± 11.6

 

 ≤ 45

32

62.7

 > 45

19

37.3

Tumor location

  

 Unilateral

20

39.2

 Bilateral

31

60.8

Tumor size (cm/mean)

1.7 ± 0.8

 

Multifocality

  

 Single

15

29.4

 Multiple (≥ 2)

36

70.6

Extracapsular invasion

  

 No

24

47.1

 Yes

27

52.9

Extrathyroid extension

  

 No

43

84.3

 Yes

8

15.7

Hashimoto’s disease

  

 No

45

88.2

 Yes

6

11.8

Central LNM

  

 No

19

37.3

 Yes

32

62.7

Lateral LNM

  

 No

34

66.7

 Yes

17

33.3

TNM stage

  

 T1

26

51.0

 T2

17

33.3

 T3

8

15.7

  1. LNM lymph node metastasis; TNM tumor-node-metastasis